113 results on '"Marletta, S"'
Search Results
2. The application of artificial intelligence to thyroid nodule assessment
- Author
-
Rizzo, P, Marletta, S, Caldonazzi, N, Nottegar, A, Eccher, A, Pagni, F, L'Imperio, V, Pantanowitz, L, Rizzo P. C., Marletta S., Caldonazzi N., Nottegar A., Eccher A., Pagni F., L'Imperio V., Pantanowitz L., Rizzo, P, Marletta, S, Caldonazzi, N, Nottegar, A, Eccher, A, Pagni, F, L'Imperio, V, Pantanowitz, L, Rizzo P. C., Marletta S., Caldonazzi N., Nottegar A., Eccher A., Pagni F., L'Imperio V., and Pantanowitz L.
- Abstract
Artificial intelligence (AI) is of considerable interest in the healthcare community including its diagnostic applications for thyroid nodules in assisting both radiology and FNA assessment. Fine-needle aspiration (FNA) helps distinguishing benign from malignant thyroid nodules and is a crucial step in the initial diagnosis of cancer. The classification of some lesions can be challenging, and the use of AI in some cases may become essential in order not to give an indeterminate result to the lesion. In this review, we summarize the available evidence regarding the application of AI in thyroid imaging and cytopathology. There are now considerable applications in digital waiting to be approved that will save time and cut costs. The published literature to date has shown promising results. However, future work is required to better define how this technology can be exploited in routine cytopathology practice.
- Published
- 2024
3. Development of an intense 10Be radioactive beam in ‘off-line mode’ at the Catania Tandem accelerator
- Author
-
Figuera, P., Maugeri, E.A., Buompane, R., Cosentino, L., Di Leva, A., Di Pietro, A., Fisichella, M., Gialanella, L., Heinitz, S., Kivel, N., Lattuada, M., Marchetta, C., Marletta, S., Mascali, D., Massara, A., Schumann, D., and Tudisco, F.
- Published
- 2020
- Full Text
- View/download PDF
4. Benchmarking digital displays (monitors) for histological diagnoses: the nephropathology use case
- Author
-
Cazzaniga, G, Mascadri, F, Marletta, S, Caputo, A, Guidi, G, Gambaro, G, Eccher, A, Dei Tos, A, Pagni, F, L'Imperio, V, Dei Tos, AP, Cazzaniga, G, Mascadri, F, Marletta, S, Caputo, A, Guidi, G, Gambaro, G, Eccher, A, Dei Tos, A, Pagni, F, L'Imperio, V, and Dei Tos, AP
- Published
- 2024
5. Artificial intelligence–based algorithms for the diagnosis of prostate cancer: A systematic review
- Author
-
Marletta, S, Eccher, A, Martelli, F, Santonicco, N, Girolami, I, Scarpa, A, Pagni, F, L’Imperio, V, Pantanowitz, L, Gobbo, S, Seminati, D, Dei Tos, A, Parwani, A, Marletta, Stefano, Eccher, Albino, Martelli, Filippo Maria, Santonicco, Nicola, Girolami, Ilaria, Scarpa, Aldo, Pagni, Fabio, L’Imperio, Vincenzo, Pantanowitz, Liron, Gobbo, Stefano, Seminati, Davide, Dei Tos, Angelo Paolo, Parwani, Anil, Marletta, S, Eccher, A, Martelli, F, Santonicco, N, Girolami, I, Scarpa, A, Pagni, F, L’Imperio, V, Pantanowitz, L, Gobbo, S, Seminati, D, Dei Tos, A, Parwani, A, Marletta, Stefano, Eccher, Albino, Martelli, Filippo Maria, Santonicco, Nicola, Girolami, Ilaria, Scarpa, Aldo, Pagni, Fabio, L’Imperio, Vincenzo, Pantanowitz, Liron, Gobbo, Stefano, Seminati, Davide, Dei Tos, Angelo Paolo, and Parwani, Anil
- Abstract
Objectives: The high incidence of prostate cancer causes prostatic samples to significantly affect pathology laboratories workflow and turnaround times (TATs). Whole-slide imaging (WSI) and artificial intelligence (AI) have both gained approval for primary diagnosis in prostate pathology, providing physicians with novel tools for their daily routine. Methods: A systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines was carried out in electronic databases to gather the available evidence on the application of AI-based algorithms to prostate cancer. Results: Of 6290 articles, 80 were included, mostly (59%) dealing with biopsy specimens. Glass slides were digitized to WSI in most studies (89%), roughly two-thirds of which (66%) exploited convolutional neural networks for computational analysis. The algorithms achieved good to excellent results about cancer detection and grading, along with significantly reduced TATs. Furthermore, several studies showed a relevant correlation between AI-identified histologic features and prognostic predictive variables such as biochemical recurrence, extraprostatic extension, perineural invasion, and disease-free survival. Conclusions: The published evidence suggests that AI can be reliably used for prostate cancer detection and grading, assisting pathologists in the time-consuming screening of slides. Further technologic improvement would help widening AI's adoption in prostate pathology, as well as expanding its prognostic predictive potential.
- Published
- 2024
6. The Puzzle of Preimplantation Kidney Biopsy Decision-Making Process: The Pathologist Perspective
- Author
-
Eccher, A, Becker, J, Pagni, F, Cazzaniga, G, Rossi, M, Gambaro, G, L'Imperio, V, Marletta, S, Becker, JU, Eccher, A, Becker, J, Pagni, F, Cazzaniga, G, Rossi, M, Gambaro, G, L'Imperio, V, Marletta, S, and Becker, JU
- Abstract
Kidney transplantation is the best treatment for end-stage renal disease since it offers the greatest survival benefit compared to dialysis. The gap between the number of renal transplants performed and the number of patients awaiting renal transplants leads to a steadily increasing pressure on the scientific community. Kidney preimplantation biopsy is used as a component of the evaluation of organ quality before acceptance for transplantation. However, the reliability and predictive value of biopsy data are controversial. Most of the previously proposed predictive models were not associated with graft survival, but what has to be reaffirmed is that histologic examination of kidney tissue can provide an objective window on the state of the organ that cannot be deduced from clinical records and renal functional studies. The balance of evidence indicates that reliable decisions about donor suitability must be made based on the overall picture. This work discusses recent trends that can reduce diagnostic timing and variability among players in the decision-making process that lead to kidney transplants, from the pathologist’s perspective.
- Published
- 2024
7. Natural Language Processing to extract SNOMED-CT codes from pathological reports
- Author
-
Cazzaniga, G, Eccher, A, Munari, E, Marletta, S, Bonoldi, E, Della Mea, V, Cadei, M, Sbaraglia, M, Guerriero, A, Dei Tos, A, Pagni, F, L'Imperio, V, Cazzaniga, Giorgio, Eccher, Albino, Munari, Enrico, Marletta, Stefano, Bonoldi, Emanuela, Della Mea, Vincenzo, Cadei, Moris, Sbaraglia, Marta, Guerriero, Angela, Dei Tos, Angelo Paolo, Pagni, Fabio, L'Imperio, Vincenzo, Cazzaniga, G, Eccher, A, Munari, E, Marletta, S, Bonoldi, E, Della Mea, V, Cadei, M, Sbaraglia, M, Guerriero, A, Dei Tos, A, Pagni, F, L'Imperio, V, Cazzaniga, Giorgio, Eccher, Albino, Munari, Enrico, Marletta, Stefano, Bonoldi, Emanuela, Della Mea, Vincenzo, Cadei, Moris, Sbaraglia, Marta, Guerriero, Angela, Dei Tos, Angelo Paolo, Pagni, Fabio, and L'Imperio, Vincenzo
- Abstract
Objective. The use of standardized structured reports (SSR) and suitable terminologies like SNOMED-CT can enhance data retrieval and analysis, fostering large-scale studies and collaboration. However, the still large prevalence of narrative reports in our laboratories warrants alternative and automated labeling approaches. In this project, natural language processing (NLP) methods were used to associate SNOMED-CT codes to structured and unstructured reports from an Italian Digital Pathology Department. Methods. Two NLP-based automatic coding systems (support vector machine, SVM, and long-short term memory, LSTM) were trained and applied to a series of narrative reports. Results. The 1163 cases were tested with both algorithms, showing good performances in terms of accuracy, precision, recall, and F1 score, with SVM showing slightly better performances as compared to LSTM (0.84, 0.87, 0.83, 0.82 vs 0.83, 0.85, 0.83, 0.82, respectively). The integration of an explainability allowed identification of terms and groups of words of importance, enabling fine-tuning, balancing semantic meaning and model performance. Conclusions. AI tools allow the automatic SNOMED-CT labeling of the pathology archives, providing a retrospective fix to the large lack of organization of narrative reports.
- Published
- 2023
8. Cutting-edge technology and automation in the pathology laboratory
- Author
-
Munari, E, Scarpa, A, Cima, L, Pozzi, M, Pagni, F, Vasuri, F, Marletta, S, Dei Tos, A, Eccher, A, Dei Tos, AP, Munari, E, Scarpa, A, Cima, L, Pozzi, M, Pagni, F, Vasuri, F, Marletta, S, Dei Tos, A, Eccher, A, and Dei Tos, AP
- Abstract
One of the goals of pathology is to standardize laboratory practices to increase the precision and effectiveness of diagnostic testing, which will ultimately enhance patient care and results. Standardization is crucial in the domains of tissue processing, analysis, and reporting. To enhance diagnostic testing, innovative technologies are also being created and put into use. Furthermore, although problems like algorithm training and data privacy issues still need to be resolved, digital pathology and artificial intelligence are emerging in a structured manner. Overall, for the field of pathology to advance and for patient care to be improved, standard laboratory practices and innovative technologies must be adopted. In this paper, we describe the state-of-the-art of automation in pathology laboratories in order to lead technological progress and evolution. By anticipating laboratory needs and demands, the aim is to inspire innovation tools and processes as positively transformative support for operators, organizations, and patients.
- Published
- 2023
9. Perspective of a Pathologist on Benchmark Strategies for Artificial Intelligence Development in Organ Transplantation
- Author
-
Eccher, A, Pagni, F, Marletta, S, Munari, E, Dei Tos, A, Eccher, Albino, Pagni, Fabio, Marletta, Stefano, Munari, Enrico, Dei Tos, Angelo Paolo, Eccher, A, Pagni, F, Marletta, S, Munari, E, Dei Tos, A, Eccher, Albino, Pagni, Fabio, Marletta, Stefano, Munari, Enrico, and Dei Tos, Angelo Paolo
- Abstract
Transplant pathology of donors is a highly specialized field comprising both the evaluation of organ donor biopsy for the oncological risk transmission and to guide the organ allocation. Timing is critical in transplant procurement since organs must be recovered as soon as possible to ensure the best possible outcome for the recipient. To all this is added the fact that the evaluation of a donor causes difficulties in many cases and the impact of these assessments is paramount, considering the possible recovery of organs that would have been erroneously discarded or, conversely, the possibly correct discarding of donors with unacceptable risk profiles. In transplant pathology histology is still the gold standard for diagnosis dictating the subsequent decisions and course of clinical care. Digital pathology has played an important role in accelerating healthcare progression and nowadays artificial intelligence powered computational pathology can effectively improve diagnostic needs, supporting the quality and safety of the process. Mapping the shape of the journey would suggest a progressive approach from supervised to semi/unsupervised models, which would involve training these models directly for clinical endpoints. In machine learning, this generally delivers better performance, compensating for a potential lack in interpretability. With planning and enough confidence in the performance of learning-based methods from digital pathology and artificial intelligence, there is great potential to augment the diagnostic quality and correlation with clinical endpoints. This may improve the donor pool and vastly reduce diagnostic and prognostic errors that are known but currently are unavoidable in transplant donor pathology.
- Published
- 2023
10. Pre-Implantation Kidney Biopsies in Extended Criteria Donors: From On Call to Expert Pathologist, from Conventional Microscope to Digital Pathology
- Author
-
Marletta, S, Di Bella, C, Catalano, G, Mastrosimini, M, Becker, J, Ernst, A, Rizzo, P, Caldonazzi, N, Vasuri, F, Malvi, D, Fanelli, G, Naccarato, G, Ghimenton, C, L'Imperio, V, Mescoli, C, Eccher, A, Furian, L, Pagni, F, Marletta, Stefano, Di Bella, Caterina, Catalano, Giovanni, Mastrosimini, Maria Gaia, Becker, Jan, Ernst, Angela, Rizzo, Paola Chiara, Caldonazzi, Nicolo, Vasuri, Francesco, Malvi, Deborah, Fanelli, Giuseppe Nicolo, Naccarato, Giuseppe, Ghimenton, Claudio, L'Imperio, Vincenzo, Mescoli, Claudia, Eccher, Albino, Furian, Lucrezia, Pagni, Fabio, Marletta, S, Di Bella, C, Catalano, G, Mastrosimini, M, Becker, J, Ernst, A, Rizzo, P, Caldonazzi, N, Vasuri, F, Malvi, D, Fanelli, G, Naccarato, G, Ghimenton, C, L'Imperio, V, Mescoli, C, Eccher, A, Furian, L, Pagni, F, Marletta, Stefano, Di Bella, Caterina, Catalano, Giovanni, Mastrosimini, Maria Gaia, Becker, Jan, Ernst, Angela, Rizzo, Paola Chiara, Caldonazzi, Nicolo, Vasuri, Francesco, Malvi, Deborah, Fanelli, Giuseppe Nicolo, Naccarato, Giuseppe, Ghimenton, Claudio, L'Imperio, Vincenzo, Mescoli, Claudia, Eccher, Albino, Furian, Lucrezia, and Pagni, Fabio
- Abstract
The number of patients awaiting a kidney transplant is constantly rising but lack of organs leads kidneys from extended criteria donors (ECD) to be used to increase the donor pool. Pre-transplant biopsies are routinely evaluated through the Karpinski-Remuzzi score but consensus on its correlation with graft survival is controversial. This study aims to test a new diagnostic model relying on digital pathology to evaluate pre-transplant biopsies and to correlate it with graft outcomes. Pre-transplant biopsies from 78 ECD utilized as single kidney transplantation were scanned, converted to whole-slide images (WSIs), and reassessed by two expert nephropathologists using the Remuzzi-Karpinski score. The correlation between graft survival at 36 months median follow-up and parameters assigned by either WSI or glass slide score (GSL) by on-call pathologists was evaluated, as well as the agreement between the GSL and the WSIs score. No relation was found between the GSL assessed by on-call pathologists and graft survival (P = 0.413). Conversely, the WSI score assigned by the two nephropathologists strongly correlated with graft loss probability, as confirmed by the ROC curves analysis (DeLong test P = 0.046). Digital pathology allows to share expertise in the transplant urgent setting, ensuring higher accuracy and favoring standardization of the process. Its employment may significantly increase the predictive capability of the pre-transplant biopsy evaluation for ECD, improving the quality of allocation and patient safety.
- Published
- 2023
11. Delphi expert consensus for whole slide imaging in thyroid cytopathology
- Author
-
Marletta, S, Salatiello, M, Pantanowitz, L, Bellevicine, C, Bongiovanni, M, Bonoldi, E, De Rezende, G, Fadda, G, Incardona, P, Munari, E, Pagni, F, Rossi, E, Tallini, G, Troncone, G, Ugolini, C, Vigliar, E, Eccher, A, Marletta, Stefano, Salatiello, Maria, Pantanowitz, Liron, Bellevicine, Claudio, Bongiovanni, Massimo, Bonoldi, Emanuela, De Rezende, Gisele, Fadda, Guido, Incardona, Paolo, Munari, Enrico, Pagni, Fabio, Rossi, Esther Diana, Tallini, Giovanni, Troncone, Giancarlo, Ugolini, Clara, Vigliar, Elena, Eccher, Albino, Marletta, S, Salatiello, M, Pantanowitz, L, Bellevicine, C, Bongiovanni, M, Bonoldi, E, De Rezende, G, Fadda, G, Incardona, P, Munari, E, Pagni, F, Rossi, E, Tallini, G, Troncone, G, Ugolini, C, Vigliar, E, Eccher, A, Marletta, Stefano, Salatiello, Maria, Pantanowitz, Liron, Bellevicine, Claudio, Bongiovanni, Massimo, Bonoldi, Emanuela, De Rezende, Gisele, Fadda, Guido, Incardona, Paolo, Munari, Enrico, Pagni, Fabio, Rossi, Esther Diana, Tallini, Giovanni, Troncone, Giancarlo, Ugolini, Clara, Vigliar, Elena, and Eccher, Albino
- Abstract
Objective: Despite an increase in thyroid fine needle aspiration (FNA) and advances in whole slide imaging (WSI) adoption, digital pathology is still considered inadequate for primary diagnosis of these cases. Herein, we aim to validate the utility of WSI in thyroid FNAs employing the Delphi method strategy. Methods: A panel of experts from seven reference cytology centres was recruited. The study consisted of two consecutive rounds: (1) an open-ended, free-response questionnaire generating a list of survey items; and (2) a consensus analysis of 80 selected shared WSIs from 80 cases by six investigators answering six morphological questions utilising a 1 to 5 Likert scale. Results: High consensus was achieved for all parameters, with an overall average score of 4.27. The broad majority of items (84%) were ranked either 4 or 5 by each physician. Two badly scanned cases were responsible for more than half of the low-ranked (≤2) values (57%). Good to excellent (≥3) diagnostic confidence was reached in more than 95.2% of cases. For most cases (78%) WSI assessment was not limited by technical issues linked to the image acquisition process. Conclusion: This systematic Delphi study indicates broad consensus among participating physicians on the application of DP to thyroid cytopathology, supporting expert opinion that WSI is reliable and safe for primary diagnostic purposes.
- Published
- 2023
12. Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma
- Author
-
Girolami, I, Marletta, S, Fiorentino, V, Battocchio, S, Cerbelli, B, Fiamengo, B, Gerosa, C, Gianatti, A, Morelli, L, Riva, G, Zagami, M, Fusco, N, Munari, E, L'Imperio, V, Pagni, F, Morbini, P, Martini, M, Eccher, A, Girolami, Ilaria, Marletta, Stefano, Fiorentino, Vincenzo, Battocchio, Simonetta, Cerbelli, Bruna, Fiamengo, Barbara, Gerosa, Clara, Gianatti, Andrea, Morelli, Luca, Riva, Giulio, Zagami, Maria Giovanna, Fusco, Nicola, Munari, Enrico, L'Imperio, Vincenzo, Pagni, Fabio, Morbini, Patrizia, Martini, Maurizio, Eccher, Albino, Girolami, I, Marletta, S, Fiorentino, V, Battocchio, S, Cerbelli, B, Fiamengo, B, Gerosa, C, Gianatti, A, Morelli, L, Riva, G, Zagami, M, Fusco, N, Munari, E, L'Imperio, V, Pagni, F, Morbini, P, Martini, M, Eccher, A, Girolami, Ilaria, Marletta, Stefano, Fiorentino, Vincenzo, Battocchio, Simonetta, Cerbelli, Bruna, Fiamengo, Barbara, Gerosa, Clara, Gianatti, Andrea, Morelli, Luca, Riva, Giulio, Zagami, Maria Giovanna, Fusco, Nicola, Munari, Enrico, L'Imperio, Vincenzo, Pagni, Fabio, Morbini, Patrizia, Martini, Maurizio, and Eccher, Albino
- Abstract
Background: Programmed death-ligand 1 (PD-L1) checkpoint inhibitors represent a mainstay of therapy in head and neck squamous cell cancer (HNSCC). However, little is known about the influence of combined therapy on PD-L1 expression. The study aims to gather evidence on this topic. Methods: A systematic search was carried out in electronic databases Pubmed-MEDLINE and Embase to retrieve studies on the comparison of PD-L1 expression before and after conventional therapy. Data were extracted and a quantitative analysis with pooled odds ratios (ORs) was performed when applicable. Results: Of 5688 items, 15 were finally included. Only a minority of studies assessed PD-L1 with the recommended combined positive score (CPS). The results are highly heterogeneous, with some studies reporting an increase in PD-L1 expression and others reporting a decrease. Three studies allowed for quantitative analysis and showed a pooled OR of 0.49 (CI 0.27–0.90). Conclusions: From the present evidence, a clear conclusion towards an increase or decrease in PD-L1 expression after combined therapy cannot be drawn, but even with few studies available, a trend towards an increase in expression in tumor cells at a cutoff of 1% can be noted in patients undergoing platinum-based therapy. Future studies will provide more robust data on the effect of combined therapy on PD-L1 expression.
- Published
- 2023
13. Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases
- Author
-
Marletta, S, L'Imperio, V, Eccher, A, Antonini, P, Santonicco, N, Girolami, I, Tos, A, Sbaraglia, M, Pagni, F, Brunelli, M, Marino, A, Scarpa, A, Munari, E, Fusco, N, Pantanowitz, L, Marletta, Stefano, L'Imperio, Vincenzo, Eccher, Albino, Antonini, Pietro, Santonicco, Nicola, Girolami, Ilaria, Tos, Angelo Paolo Dei, Sbaraglia, Marta, Pagni, Fabio, Brunelli, Matteo, Marino, Andrea, Scarpa, Aldo, Munari, Enrico, Fusco, Nicola, Pantanowitz, Liron, Marletta, S, L'Imperio, V, Eccher, A, Antonini, P, Santonicco, N, Girolami, I, Tos, A, Sbaraglia, M, Pagni, F, Brunelli, M, Marino, A, Scarpa, A, Munari, E, Fusco, N, Pantanowitz, L, Marletta, Stefano, L'Imperio, Vincenzo, Eccher, Albino, Antonini, Pietro, Santonicco, Nicola, Girolami, Ilaria, Tos, Angelo Paolo Dei, Sbaraglia, Marta, Pagni, Fabio, Brunelli, Matteo, Marino, Andrea, Scarpa, Aldo, Munari, Enrico, Fusco, Nicola, and Pantanowitz, Liron
- Abstract
Infectious diseases still threaten the global community, especially in resource-limited countries. An accurate diagnosis is paramount to proper patient and public health management. Identification of many microbes still relies on manual microscopic examination, a time-consuming process requiring skilled staff. Thus, artificial intelligence (AI) has been exploited for identification of microorganisms. A systematic search was carried out using electronic databases looking for studies dealing with the application of AI to pathology microbiology specimens. Of 4596 retrieved articles, 110 were included. The main applications of AI regarded malaria (54 studies), bacteria (28), nematodes (14), and other protozoa (11). Most publications examined cytological material (95, 86%), mainly analyzing images acquired through microscope cameras (65, 59%) or coupled with smartphones (16, 15%). Various deep-learning strategies were used for the analysis of digital images, achieving highly satisfactory results. The published evidence suggests that AI can be reliably utilized for assisting pathologists in the detection of microorganisms. Further technologic improvement and availability of datasets for training AI-based algorithms would help expand this field and widen its adoption, especially for developing countries.
- Published
- 2023
14. mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy
- Author
-
Calio, A., Marletta, S., Settanni, G., Rizzo, M., Gobbo, S., Pedron, S., Stefanizzi, L., Munari, E., Brunelli, M., Marcolini, L., Pesci, A., Fratoni, S., Pierconti, Francesco, Raspollini, M. R., Marchetti, A., Doglioni, C., Amin, M. B., Porta, C., Martignoni, G., Pierconti F. (ORCID:0000-0003-0951-4131), Calio, A., Marletta, S., Settanni, G., Rizzo, M., Gobbo, S., Pedron, S., Stefanizzi, L., Munari, E., Brunelli, M., Marcolini, L., Pesci, A., Fratoni, S., Pierconti, Francesco, Raspollini, M. R., Marchetti, A., Doglioni, C., Amin, M. B., Porta, C., Martignoni, G., and Pierconti F. (ORCID:0000-0003-0951-4131)
- Abstract
In the spectrum of oncocytic renal neoplasms, a subset of tumors with high-grade-appearing histologic features harboring pathogenic mutations in mammalian target of rapamycin (mTOR) and hitherto clinical indolent behavior has been described. Three cases (2F,1 M) with histologically documented metastases (lymph node, skull, and liver) were retrieved and extensively investigated by immunohistochemistry, FISH, and next-generation sequencing. Tumors were composed of eosinophilic cells with prominent nucleoli (G3 by ISUP/WHO) arranged in solid to nested architecture. Additionally, there were larger cells with perinuclear cytoplasmic shrinkage and sparse basophilic Nissl-like granules, superficially resembling the so-called spider cells of cardiac rhabdomyomas. The renal tumors, including the skull and liver metastases, showed immunoexpression PAX8, CK8-18, and cathepsin-K, and negativity for vimentin. NGS identified mTOR genetic alterations in the three cases, including the skull and liver metastases. One patient was then treated with Everolimus (mTOR inhibitors) with clinical response (metastatic tumor shrinkage). We present a distinct renal tumor characterized by high-grade eosinophilic cells, cathepsin-K immunohistochemical expression, and harboring mTOR gene mutations demonstrating a malignant potential and showing responsiveness to mTOR inhibitors.
- Published
- 2023
15. AISHa: an ECRIS for nuclear-physics, new clinical protocols and material experiments.
- Author
-
Celona, L., Leonardi, O., Castro, G., Gammino, S., Neri, L., Costanzo, G., Chines, F., Siliato, D., Passerello, S., Russo, F., Calabrese, G., Marletta, S., Vercesi, V., Lanza, A., Kourkoumeli, A, Ramos, R. L., Scagliotti, C., Vercellati, F., Falbo, L., and Maugeri, C.
- Published
- 2023
- Full Text
- View/download PDF
16. Artificial intelligence applications for pre-implantation kidney biopsy pathology practice: a systematic review
- Author
-
Girolami, I., Pantanowitz, L., Marletta, S., Hermsen, M., Laak, J.A.W.M. van der, Munari, E., Furian, L., Vistoli, F., Zaza, G., Cardillo, M., Gesualdo, L., Gambaro, G., Eccher, A., Girolami, I., Pantanowitz, L., Marletta, S., Hermsen, M., Laak, J.A.W.M. van der, Munari, E., Furian, L., Vistoli, F., Zaza, G., Cardillo, M., Gesualdo, L., Gambaro, G., and Eccher, A.
- Abstract
Contains fulltext : 283491.pdf (Publisher’s version ) (Open Access), BACKGROUND: Transplant nephropathology is a highly specialized field of pathology comprising both the evaluation of organ donor biopsy for organ allocation and post-transplant graft biopsy for assessment of rejection or graft damage. The introduction of digital pathology with whole-slide imaging (WSI) in clinical research, trials and practice has catalyzed the application of artificial intelligence (AI) for histopathology, with development of novel machine-learning models for tissue interrogation and discovery. We aimed to review the literature for studies specifically applying AI algorithms to WSI-digitized pre-implantation kidney biopsy. METHODS: A systematic search was carried out in the electronic databases PubMed-MEDLINE and Embase until 25th September, 2021 with a combination of the key terms "kidney", "biopsy", "transplantation" and "artificial intelligence" and their aliases. Studies dealing with the application of AI algorithms coupled with WSI in pre-implantation kidney biopsies were included. The main theme addressed was detection and quantification of tissue components. Extracted data were: author, year and country of the study, type of biopsy features investigated, number of cases, type of algorithm deployed, main results of the study in terms of diagnostic outcome, and the main limitations of the study. RESULTS: Of 5761 retrieved articles, 7 met our inclusion criteria. All studies focused largely on AI-based detection and classification of glomerular structures and to a lesser extent on tubular and vascular structures. Performance of AI algorithms was excellent and promising. CONCLUSION: All studies highlighted the importance of expert pathologist annotation to reliably train models and the need to acknowledge clinical nuances of the pre-implantation setting. Close cooperation between computer scientists and practicing as well as expert renal pathologists is needed, helping to refine the performance of AI-based models for routine pre-implantation kidne
- Published
- 2022
17. Hot topics in renal cancer pathology: implications for clinical management
- Author
-
Cimadamore, A., Caliò, A., Marandino, L., Marletta, S., Franzese, C., Schips, L., Amparore, D., Bertolo, R., Muselaers, S., Erdem, S., Ingels, A., Pavan, N., Pecoraro, A., Kara, Ö., Roussel, E., Carbonara, U., Campi, R., Marchioni, M., Cimadamore, A., Caliò, A., Marandino, L., Marletta, S., Franzese, C., Schips, L., Amparore, D., Bertolo, R., Muselaers, S., Erdem, S., Ingels, A., Pavan, N., Pecoraro, A., Kara, Ö., Roussel, E., Carbonara, U., Campi, R., and Marchioni, M.
- Abstract
Item does not contain fulltext, INTRODUCTION: The updated European Association of Urology (EAU) Guidelines issued a weak recommendation for adjuvant pembrolizumab for patients with high-risk operable clear cell Renal Cell Carcinoma (ccRCC). High risk of recurrence was defined, as per protocol-criteria, as T2 with nuclear grade 4 or sarcomatoid differentiation, T3 or higher, regional lymph node metastasis, or stage M1 with no evidence of disease. Considering the heterogeneous population included in the recommendation, it has been questioned if adjuvant pembrolizumab may lead to overtreatment of some patients as well as undertreatment of patients with worse prognosis. AREAS COVERED: In this review, we discuss the issues related to the assessment of pathological features required to identify those patients harboring a high-risk tumor, highlighting the issue related to interobserver variability and discuss the currently available prognostic scoring systems in ccRCC. EXPERT OPINION: PPathologist assessment of prognostic features suffers from interobserver variability which may depend on gross sampling and the pathologist's expertise. The presence of clear cell feature is not sufficient criteria by itself to define ccRCC since clear cell can be also found in other histotypes. Application of molecular biomarkers may be useful tools in the near future to help clinicians identify patients harboring tumors with worse prognosis.
- Published
- 2022
18. Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems
- Author
-
Marletta, S, Fusco, N, Munari, E, Luchini, C, Cimadamore, A, Brunelli, M, Querzoli, G, Martini, M, Vigliar, E, Colombari, R, Girolami, I, Pagni, F, Eccher, A, Marletta, Stefano, Fusco, Nicola, Munari, Enrico, Luchini, Claudio, Cimadamore, Alessia, Brunelli, Matteo, Querzoli, Giulia, Martini, Maurizio, Vigliar, Elena, Colombari, Romano, Girolami, Ilaria, Pagni, Fabio, Eccher, Albino, Marletta, S, Fusco, N, Munari, E, Luchini, C, Cimadamore, A, Brunelli, M, Querzoli, G, Martini, M, Vigliar, E, Colombari, R, Girolami, I, Pagni, F, Eccher, A, Marletta, Stefano, Fusco, Nicola, Munari, Enrico, Luchini, Claudio, Cimadamore, Alessia, Brunelli, Matteo, Querzoli, Giulia, Martini, Maurizio, Vigliar, Elena, Colombari, Romano, Girolami, Ilaria, Pagni, Fabio, and Eccher, Albino
- Abstract
Background. Innovative drugs targeting the PD1/PD-L1 axis have opened promising sce-narios in modern cancer therapy. Plenty of assays and scoring systems have been developed for the evaluation of PD-L1 immunohistochemical expression, so far considered the most reliable therapeutic predictive marker. Methods. By gathering the opinion of acknowledged experts in dedicated fields of pathology, we sought to update the currently available evidence on PD-L1 assessment in various types of tumors. Results. Robust data were progressively collected for several anatomic districts and leading international agencies to approve specific protocols: among these, TPS with 22C3, SP142 and SP263 clones in lung cancer; IC with SP142 antibody in breast, lung and urothelial tumors; and CPS with 22C3/SP263 assays in head and neck and urothelial carcinomas. On the other hand, for other malignancies, such as gastroenteric neoplasms, immunotherapy has been only recently introduced, often for particular histotypes, so specific guidelines are still lacking. Conclu-sions. PD-L1 immunohistochemical scoring is currently the basis for allowing many cancer patients to receive properly targeted therapies. While protocols supported by proven data are already available for many tumors, dedicated studies and clinical trials focusing on harmonization of the topic in other still only partially explored fields are surely yet advisable.
- Published
- 2022
19. Design and first operations of a ECR based He source at INFN-LNS
- Author
-
Mazzaglia, M., primary, Amato, A.S., additional, Battiato, G., additional, Calabrese, G., additional, Celona, L., additional, Cosentino, L. G., additional, Dantoni, L., additional, Gammino, S., additional, Manno, G., additional, Marletta, S., additional, Massara, A., additional, Maugeri, A., additional, Mauro, G. S., additional, Miraglia, A., additional, Naselli, E., additional, Passarello, S., additional, Pidatella, A., additional, Piscopo, M., additional, Russo, A. D., additional, Seminara, A., additional, Siliato, D., additional, Torrisi, G., additional, Tudisco, D., additional, Vecchio, G., additional, Vinciguerra, S., additional, Mascali, D., additional, and Galatá, A., additional
- Published
- 2022
- Full Text
- View/download PDF
20. Morphological and immunohistochemical approach to the diagnosis of vulvo-vaginal stromal tumors
- Author
-
Angelico, G., Spadola, S., Morante, B., Salvatorelli, L., Marletta, S., and Magro, G.
- Published
- 2022
21. Preoperative Predictors of R0 Resection after Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinoma
- Author
-
Bao, Q.R., primary, Frigerio, I., additional, Spolverato, G., additional, Chiminazzo, V., additional, Marletta, S., additional, Giardino, A., additional, Girelli, R., additional, and Butturini, G., additional
- Published
- 2022
- Full Text
- View/download PDF
22. Advantages of Using a Web-based Digital Platform for Kidney Preimplantation Biopsies
- Author
-
Neri, F, Eccher, A, Rigotti, P, Girolami, I, Zaza, G, Gambaro, G, Mastrosimini, M, Bencini, G, Di Bella, C, Mescoli, C, Boschiero, L, Marletta, S, Dei Tos, P, Furian, L, Dei Tos, PA, Neri, F, Eccher, A, Rigotti, P, Girolami, I, Zaza, G, Gambaro, G, Mastrosimini, M, Bencini, G, Di Bella, C, Mescoli, C, Boschiero, L, Marletta, S, Dei Tos, P, Furian, L, and Dei Tos, PA
- Abstract
Background: In the setting of kidney transplantation, histopathology of kidney biopsies is a key element in the organ assessment and allocation. Despite the broad diffusion of the Remuzzi-Karpinski score on preimplantation kidney biopsies, scientific evidence of its correlation to the transplantation outcome is controversial. The main issues affecting the prognostic value of histopathology are the referral to general on-call pathologists and the semiquantitative feature of the score, which can raise issues of interpretation. Digital pathology has shown very reliable and effective in the oncological diagnosis and treatment; however, the spread of such technologies is lagging behind in the field of transplantation. The aim of our study was to create a digital online platform where whole-slide images (WSI) of preimplantation kidney biopsies could be uploaded and stored. Methods: We included 210 kidney biopsies collected between January 2015 and December 2019 from the joint collaboration of the transplantation centers of Padua and Verona. The selected slides, stained with hematoxylin and eosin, were digitized and uploaded on a shared web platform. For each case, the on-call pathologists' Remuzzi grades were obtained from the original report, together with the clinical data and the posttransplantation follow-up. Results: The storage of WSI of preimplantation kidney biopsies would have several clinical, scientific, and educational advantages. The clinical utility relies on the possibility to consult online expert pathologists and real-time quality checks of diagnosis. From the perspective of follow-up, the archived digitized biopsies can offer a useful comparison to posttransplantation biopsies. In addition, the digital online platform is a precious tool for multidisciplinary meetings aimed both at the clinical discussion and at the design of research projects. Furthermore, this archive of readily available WSI is an important educational resource for the training of prof
- Published
- 2021
23. Predictors of major pathological response after neoadjuvant therapy for borderline and locally advanced pancreatic ductal adenocarcinoma.
- Author
-
Bao, Quoc Riccardo, Frigerio, I., Tripepi, M., Marletta, S., Martignoni, G., Giardino, A., Regi, P., Scopelliti, F., Allegrini, V., Girelli, R., Spolverato, G., and Butturini, G.
- Published
- 2022
- Full Text
- View/download PDF
24. Experimental investigation of exotic clustering in 13B and 14C using the resonance scattering method.
- Author
-
SCOAP, Pietro, A. di, Fernández-García, J. P., Ferrera, F., Figuera, P., Fisichella, M., Lattuada, M., Marletta, S., Marchetta, C., Torresi, D., Alcorta, Martín, García Borge, María José, Davinson, T., Heinitz, S., Laird, A.M., Shotter, A. C., Schumann, D., Soic, N., Tengblad, Olof, Zadro, M., SCOAP, Pietro, A. di, Fernández-García, J. P., Ferrera, F., Figuera, P., Fisichella, M., Lattuada, M., Marletta, S., Marchetta, C., Torresi, D., Alcorta, Martín, García Borge, María José, Davinson, T., Heinitz, S., Laird, A.M., Shotter, A. C., Schumann, D., Soic, N., Tengblad, Olof, and Zadro, M.
- Abstract
In order to investigate the existence of molecular and/or exotic cluster configurations in Boron and Carbon n-rich isotopes we undertook two experiments: the first experimental study of exotic 9Li+¿ cluster states in 13B using the resonance scattering method at TRIUMF (Canada), and, with the same technique, the measurement of 10Be+¿ scattering at LNS in Catania, where a 10Be radioactive beam was produced for the first time. In order to measure the excitation function in a wide energy range, the beams were stopped in a Helium-flooded chamber. In the case of 13B, the elastic excitation function shows the presence of various peaks in an excitation energy region never explored before. In the case of 14C, our exclusive measurement of elastic scattering data with a high intensity beam, sheds some light on the contradictory previously published results [1, 2].
- Published
- 2018
25. Experimental investigation of exotic clustering in 13B and 14C using the resonance scattering method
- Author
-
Di Pietro, A., primary, Fernández-García, J. P., additional, Ferrera, F., additional, Figuera, P., additional, Fisichella, M., additional, Lattuada, M., additional, Marletta, S., additional, Marchetta, C., additional, Torresi, D., additional, Alcorta, M., additional, Borge, M. J. G., additional, Davinson, T., additional, Heinitz, S., additional, Laird, A. M., additional, Shotter, A. C., additional, Schumann, D., additional, Soic, N., additional, Tengblad, O., additional, and Zadro, M., additional
- Published
- 2018
- Full Text
- View/download PDF
26. Commissioning of the AISHa ion source at INFN-LNS
- Author
-
Celona, L., primary, Castro, G., additional, Chines, F., additional, Costa, G., additional, Gammino, S., additional, Leonardi, O., additional, Marletta, S., additional, Mascali, D., additional, Maugeri, A., additional, Neri, L., additional, Noto, F. M., additional, Passarello, S., additional, Pastore, G., additional, Seminara, A., additional, Torrisi, G., additional, Vinciguerra, S., additional, Di Martino, S., additional, and Nicotra, P., additional
- Published
- 2018
- Full Text
- View/download PDF
27. Beam commission of the high intensity proton source developed at INFN-LNS for the European Spallation Source
- Author
-
Neri, L, primary, Celona, L, additional, Gammino, S, additional, Miraglia, A, additional, Leonardi, O, additional, Castro, G, additional, Torrisi, G, additional, Mascali, D, additional, Mazzaglia, M, additional, Allegra, L, additional, Amato, A, additional, Calabrese, G, additional, Caruso, A, additional, Chines, F, additional, Gallo, G, additional, Longhitano, A, additional, Manno, G, additional, Marletta, S, additional, Maugeri, A, additional, Passarello, S, additional, Pastore, G, additional, Seminara, A, additional, Spartà, A, additional, and Vinciguerra, S, additional
- Published
- 2017
- Full Text
- View/download PDF
28. Commissioning of the AISHa Ion Source at INFN-LNS.
- Author
-
Celona, L., Castro, G., Chines, F., Costa, G., Gammino, S., Leonardi, O., Marletta, S., Mascali, D., Maugeri, A., Neri, L., Noto, F. M., Passarello, S., Pastore, G., Seminara, A., Torrisi, G., Vinciguerra, S., Di Martino, S., and Nicotra, P.
- Subjects
ION sources ,ION beams ,PERMANENT magnets ,SUPERCONDUCTING magnets ,MAGNETIC fields - Abstract
The new AISHa ion source has been designed to generate high brightness multiply charged ion beams for hadrontheraphy applications, with high reliability, easy operations and fast maintenance. In order to get a compact machine the radial confinement is provided by a Hallbach-type permanent magnet hexapole structure, while axial confinement is allowed by four high field He-free superconducting magnets, allowing the optimization of the magnetic field gradient at ECR resonance. The present work shows the results of ion source commissioning along with next developments. Innovative active coupling techniques are planned to be tested to optimize the first pass wave absorption, which plays an important role in the coupling optimization of the new generation ECRIS. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
29. Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma
- Author
-
Ilaria Girolami, Stefano Marletta, Vincenzo Fiorentino, Simonetta Battocchio, Bruna Cerbelli, Barbara Fiamengo, Clara Gerosa, Andrea Gianatti, Luca Morelli, Giulio Riva, Maria Giovanna Zagami, Nicola Fusco, Enrico Munari, Vincenzo L’Imperio, Fabio Pagni, Patrizia Morbini, Maurizio Martini, Albino Eccher, Girolami, I, Marletta, S, Fiorentino, V, Battocchio, S, Cerbelli, B, Fiamengo, B, Gerosa, C, Gianatti, A, Morelli, L, Riva, G, Zagami, M, Fusco, N, Munari, E, L'Imperio, V, Pagni, F, Morbini, P, Martini, M, and Eccher, A
- Subjects
programmed death-ligand 1 ,systematic review ,immunohistochemistry ,radio-chemotherapy ,Medicine (miscellaneous) ,immunotherapy ,head and neck squamous cell carcinoma - Abstract
Background: Programmed death-ligand 1 (PD-L1) checkpoint inhibitors represent a mainstay of therapy in head and neck squamous cell cancer (HNSCC). However, little is known about the influence of combined therapy on PD-L1 expression. The study aims to gather evidence on this topic. Methods: A systematic search was carried out in electronic databases Pubmed-MEDLINE and Embase to retrieve studies on the comparison of PD-L1 expression before and after conventional therapy. Data were extracted and a quantitative analysis with pooled odds ratios (ORs) was performed when applicable. Results: Of 5688 items, 15 were finally included. Only a minority of studies assessed PD-L1 with the recommended combined positive score (CPS). The results are highly heterogeneous, with some studies reporting an increase in PD-L1 expression and others reporting a decrease. Three studies allowed for quantitative analysis and showed a pooled OR of 0.49 (CI 0.27–0.90). Conclusions: From the present evidence, a clear conclusion towards an increase or decrease in PD-L1 expression after combined therapy cannot be drawn, but even with few studies available, a trend towards an increase in expression in tumor cells at a cutoff of 1% can be noted in patients undergoing platinum-based therapy. Future studies will provide more robust data on the effect of combined therapy on PD-L1 expression.
- Published
- 2023
30. Relevance of the College of American Pathologists' Guideline for Validating Whole Slide Imaging for Diagnostic Purposes to Cytopathology
- Author
-
Pietro Antonini, Nicola Santonicco, Liron Pantanowitz, Ilaria Girolami, Paola Chiara Rizzo, Matteo Brunelli, Claudio Bellevicine, Elena Vigliar, Giovanni Negri, Giancarlo Troncone, Guido Fadda, Anil Parwani, Stefano Marletta, Albino Eccher, Antonini, P, Santonicco, N, Pantanowitz, L, Girolami, I, Rizzo, Pc, Brunelli, M, Bellevicine, C, Vigliar, E, Negri, G, Troncone, G, Fadda, G, Parwani, A, Marletta, S, and Eccher, A.
- Subjects
Observer Variation ,WSI ,validation ,Microscopy ,Histology ,Cytodiagnosis ,CAP guideline ,General Medicine ,CAP guidelines ,Pathology and Forensic Medicine ,cytopathology ,systematic review ,Image Interpretation, Computer-Assisted ,Humans ,Laboratories ,digital pathology - Abstract
Whole slide imaging (WSI) allows pathologists to view virtual versions of slides on computer monitors. With increasing adoption of digital pathology, laboratories have begun to validate their WSI systems for diagnostic purposes according to reference guidelines. Among these the College of American Pathologists (CAP) guideline includes three strong recommendations (SRs) and nine good practice statements (GPSs). To date, the application of WSI to cytopathology has been beyond the scope of the CAP guideline due to limited evidence. Herein we systematically reviewed the published literature on WSI validation studies in cytology. A systematic search was carried out in PubMed-MEDLINE and Embase databases up to November 2021 to identify all publications regarding validation of WSI in cytology. Each article was reviewed to determine if SRs and/or GPSs recommended by the CAP guideline were adequately satisfied. Of 3963 retrieved articles, 25 were included. Only 4/25 studies (16%) satisfied all three SRs, with only one publication (1/25, 4%) fulfilling all three SRs and nine GPSs. Lack of a suitable validation dataset was the main missing SR (16/25, 64%) and less than a third of the studies reported intra-observer variability data (7/25, 28%). Whilst the CAP guideline for WSI validation in clinical practice helped the widespread adoption of digital pathology, more evidence is required to routinely employ WSI for diagnostic purposes in cytopathology practice. More dedicated validation studies satisfying all SRs and/or GPSs recommended by the CAP are needed to help expedite the use of WSI for primary diagnosis in cytopathology.
- Published
- 2023
31. Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases
- Author
-
Stefano Marletta, Vincenzo L’Imperio, Albino Eccher, Pietro Antonini, Nicola Santonicco, Ilaria Girolami, Angelo Paolo Dei Tos, Marta Sbaraglia, Fabio Pagni, Matteo Brunelli, Andrea Marino, Aldo Scarpa, Enrico Munari, Nicola Fusco, Liron Pantanowitz, Marletta, S, L'Imperio, V, Eccher, A, Antonini, P, Santonicco, N, Girolami, I, Tos, A, Sbaraglia, M, Pagni, F, Brunelli, M, Marino, A, Scarpa, A, Munari, E, Fusco, N, and Pantanowitz, L
- Subjects
Cytopathology ,Infectious disease ,Microorganism ,Artificial intelligence ,Microorganisms ,Infectious diseases ,Deep learning ,Cell Biology ,Malaria ,Pathology and Forensic Medicine - Abstract
Infectious diseases still threaten the global community, especially in resource-limited countries. An accurate diagnosis is paramount to proper patient and public health management. Identification of many microbes still relies on manual microscopic examination, a time-consuming process requiring skilled staff. Thus, artificial intelligence (AI) has been exploited for identification of microorganisms. A systematic search was carried out using electronic databases looking for studies dealing with the application of AI to pathology microbiology specimens. Of 4596 retrieved articles, 110 were included. The main applications of AI regarded malaria (54 studies), bacteria (28), nematodes (14), and other protozoa (11). Most publications examined cytological material (95, 86%), mainly analyzing images acquired through microscope cameras (65, 59%) or coupled with smartphones (16, 15%). Various deep-learning strategies were used for the analysis of digital images, achieving highly satisfactory results. The published evidence suggests that AI can be reliably utilized for assisting pathologists in the detection of microorganisms. Further technologic improvement and availability of datasets for training AI-based algorithms would help expand this field and widen its adoption, especially for developing countries.
- Published
- 2023
32. Application of Digital Imaging and Artificial Intelligence to Pathology of the Placenta
- Author
-
Stefano Marletta, Liron Pantanowitz, Nicola Santonicco, Alessandro Caputo, Emma Bragantini, Matteo Brunelli, Ilaria Girolami, Albino Eccher, Marletta, S., Pantanowitz, L., Santonicco, N., Caputo, A., Bragantini, E., Brunelli, M., Girolami, I., and Eccher, A.
- Subjects
3D-imaging ,placenta ,systematic review ,Pediatrics, Perinatology and Child Health ,digital pathology ,whole slide imaging ,General Medicine ,Pathology and Forensic Medicine - Abstract
Digital imaging, including the use of artificial intelligence, has been increasingly applied to investigate the placenta and its related pathology. However, there has been no comprehensive review of this body of work to date. The aim of this study was to therefore review the literature regarding digital pathology of the placenta. A systematic literature search was conducted in several electronic databases. Studies involving the application of digital imaging and artificial intelligence techniques to human placental samples were retrieved and analyzed. Relevant articles were categorized by digital image technique and their relevance to studying normal and diseased placenta. Of 2008 retrieved articles, 279 were included. Digital imaging research related to the placenta was often coupled with immunohistochemistry, confocal microscopy, 3D reconstruction, and/or deep learning algorithms. By significantly increasing pathologists’ ability to recognize potentially prognostic relevant features and by lessening inter-observer variability, published data overall indicate that the application of digital pathology to placental and perinatal diseases, along with clinical and radiology correlation, has great potential to improve fetal and maternal health care including the selection of targeted therapy in high-risk pregnancy.
- Published
- 2022
33. Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems
- Author
-
Stefano Marletta, Nicola Fusco, Enrico Munari, Claudio Luchini, Alessia Cimadamore, Matteo Brunelli, Giulia Querzoli, Maurizio Martini, Elena Vigliar, Romano Colombari, Ilaria Girolami, Fabio Pagni, Albino Eccher, Marletta, S, Fusco, N, Munari, E, Luchini, C, Cimadamore, A, Brunelli, M, Querzoli, G, Martini, M, Vigliar, E, Colombari, R, Girolami, I, Pagni, F, and Eccher, A
- Subjects
clone ,PD-L1 ,scores ,clones ,immunohistochemistry ,score ,Medicine (miscellaneous) ,immunotherapy ,Settore MED/08 - Anatomia Patologica - Abstract
Background. Innovative drugs targeting the PD1/PD-L1 axis have opened promising scenarios in modern cancer therapy. Plenty of assays and scoring systems have been developed for the evaluation of PD-L1 immunohistochemical expression, so far considered the most reliable therapeutic predictive marker. Methods. By gathering the opinion of acknowledged experts in dedicated fields of pathology, we sought to update the currently available evidence on PD-L1 assessment in various types of tumors. Results. Robust data were progressively collected for several anatomic districts and leading international agencies to approve specific protocols: among these, TPS with 22C3, SP142 and SP263 clones in lung cancer; IC with SP142 antibody in breast, lung and urothelial tumors; and CPS with 22C3/SP263 assays in head and neck and urothelial carcinomas. On the other hand, for other malignancies, such as gastroenteric neoplasms, immunotherapy has been only recently introduced, often for particular histotypes, so specific guidelines are still lacking. Conclusions. PD-L1 immunohistochemical scoring is currently the basis for allowing many cancer patients to receive properly targeted therapies. While protocols supported by proven data are already available for many tumors, dedicated studies and clinical trials focusing on harmonization of the topic in other still only partially explored fields are surely yet advisable.
- Published
- 2022
34. Donor-Transmitted Cancers in Transplanted Livers: Analysis of Clinical Outcomes
- Author
-
Ilaria Girolami, Deborah Malvi, Matteo Brunelli, Letizia Lombardini, Amedeo Carraro, Claudia Mescoli, Albino Eccher, Umberto Montin, Stefano Marletta, Desley Neil, Massimo Cardillo, Luca Novelli, Ugo Boggi, Antonietta D'Errico, Eccher A., Girolami I., Marletta S., Brunelli M., Carraro A., Montin U., Boggi U., Mescoli C., Novelli L., Malvi D., Lombardini L., Cardillo M., Neil D., and D'Errico A.
- Subjects
Oncology ,medicine.medical_specialty ,liver grafts ,medicine.medical_treatment ,cancer transmission ,Transplants ,030230 surgery ,Neuroendocrine tumors ,Liver transplantation ,Malignancy ,donor organ ,liver recipients ,systematic review ,03 medical and health sciences ,0302 clinical medicine ,Neoplasms ,Internal medicine ,medicine ,Humans ,Registries ,Liver transplantation, cancer transmissio ,Transplantation ,Hepatology ,business.industry ,Transmission (medicine) ,Melanoma ,Graft Survival ,Cancer ,medicine.disease ,Tissue Donors ,Liver Transplantation ,Lymphoma ,030211 gastroenterology & hepatology ,Surgery ,business - Abstract
The risk of transmission of malignancy from donor to recipient is low. However, this occurrence has dramatic consequences. Many reports of donor-derived cancers in liver transplant recipients have been published, but they have not been systematically summarized into a lucid and unified analysis. The present study is an attempt to provide clarity to this unusual but clinically important problem. We systematically reviewed all patient reports, patient series, and registries published on cancer transmission events through the end of December 2019. We identified a total of 67 publications with 92 transmission events. The most frequently transmitted cancers were lymphomas (30; 32.6%), melanomas (8; 8.7%), and neuroendocrine tumors (8; 8.7%). Most of the melanomas were metastasizing, whereas most of the lymphomas were localized to the graft. The median time to cancer diagnosis after transplantation was 7months, with 78.1% of diagnoses established in the first year. Melanoma carried the worst prognosis, with no recipients alive at 1year after cancer diagnosis. Lymphoma recipients had a better outcome, with more than 75% surviving at 2years. A metastatic cancer carries a worse prognosis for recipients, and recipients with localized cancer can benefit from the chance to undergo transplantation again. The findings confirm the need to pay attention to donors with a history of melanoma but also suggest the need for a more careful evaluation of groups of donors, such as those dying from cerebral hemorrhage. Finally, recipients of organs from donors with cancer should be carefully followed to detect potential transmission.
- Published
- 2021
35. Donor-transmitted cancer in kidney transplant recipients: a systematic review
- Author
-
Gianluigi Zaza, Ugo Boggi, Letizia Lombardini, Stefano Marletta, Jennifer D. Motter, Massimo Cardillo, Luigino Boschiero, Paola Donato, Albino Eccher, Giovanni Gambaro, Antonietta D'Errico, Francesco Nacchia, Rostand Emmanuel Nguefuet Momo, D. Neil, Ilaria Girolami, Dorry L. Segev, Eccher A., Girolami I., Motter J.D., Marletta S., Gambaro G., Momo R.E.N., Nacchia F., Donato P., Boschiero L., Boggi U., Lombardini L., Cardillo M., D'Errico A., Neil D., Segev D.L., and Zaza G.
- Subjects
Oncology ,Nephrology ,medicine.medical_specialty ,Lung Neoplasms ,Disease transmission ,030232 urology & nephrology ,030230 surgery ,Metastasis ,Kidney transplantation ,03 medical and health sciences ,0302 clinical medicine ,Carcinoma, Non-Small-Cell Lung ,Internal medicine ,medicine ,Humans ,Lung cancer ,business.industry ,Melanoma ,Graft Survival ,Choriocarcinoma ,Cancer ,Donor-transmitted cancer ,Systematic review ,medicine.disease ,Kidney Neoplasms ,Tissue Donors ,Transplant Recipients ,Lymphoma ,Original Article ,business - Abstract
The transmission of cancer from a donor organ is a rare event but has important consequences. Aim of this systematic review was to summarize all the published evidence on cancer transmission in kidney recipients. We reviewed published case reports and series describing the outcome of recipients with donor-transmitted cancer until August 2019. A total of 128 papers were included, representing 234 recipients. The most common transmitted cancers were lymphoma (n = 48, 20.5%), renal cancer (42, 17.9%), melanoma (40, 17.1%), non-small cell lung cancer (n = 13, 5.6%), neuroendocrine cancers comprising small cell lung cancer (n = 11, 4.7%) and choriocarcinoma (n = 10, 4.3%). There was a relative lack of glioblastoma and gastrointestinal cancers with only 6 and 5 cases, respectively. Melanoma and lung cancer had the worst prognosis, with 5-years overall survival of 43% and 19%, respectively; while renal cell cancer and lymphomas had a favorable prognosis with 5-years overall survival of 93 and 63%, respectively. Metastasis of cancer outside the graft was the most important adverse prognostic factor. Overall reporting was good, but information on donors’ cause of death and investigations at procurement was often lacking. Epidemiology of transmitted cancer has evolved, thanks to screening with imaging and blood tests, as choriocarcinoma transmission have almost abolished, while melanoma and lymphoma are still difficult to detect and prevent. Electronic supplementary material The online version of this article (10.1007/s40620-020-00775-4) contains supplementary material, which is available to authorized users.
- Published
- 2020
36. Development of an intense 10Be radioactive beam in ‘off-line mode’ at the Catania Tandem accelerator
- Author
-
S. Heinitz, P. Figuera, Dorothea Schumann, Raffaele Buompane, David Mascali, C. Marchetta, Maria Fisichella, Lucio Gialanella, F. Tudisco, Emilio Andrea Maugeri, A. Massara, A. Di Leva, M. Lattuada, L. Cosentino, A. Di Pietro, S. Marletta, Niko Kivel, Figuera, P., Maugeri, E. A., Buompane, R., Cosentino, L., Di Leva, A., Di Pietro, A., Fisichella, M., Gialanella, L., Heinitz, S., Kivel, N., Lattuada, M., Marchetta, C., Marletta, S., Mascali, D., Massara, A., Schumann, D., and Tudisco, F.
- Subjects
Physics ,Nuclear and High Energy Physics ,Muon ,Tandem ,Proton ,010308 nuclear & particles physics ,Be ,Tandem accelerator ,01 natural sciences ,Cathode ,law.invention ,Nuclear physics ,law ,0103 physical sciences ,Irradiation ,010306 general physics ,Instrumentation ,Radioactive beam ,Beam (structure) ,Radioactive beams - Abstract
A 10Be beam having intensities up to 3 enA has been accelerated at the Tandem of the Laboratori Nazionali del Sud in Catania. The used 10Be was chemically extracted from a proton irradiated graphite target used for muon production at the Paul Scherrer Institute. In order to maximise the extracted current using a minimum amount of isotope, several preparatory tests, needed to optimise the preparation of the Tandem sputter source cathodes, were performed. The acceleration tests and accelerated beam characteristics will be discussed and examples of beam use for nuclear structure investigations will be presented.
- Published
- 2020
37. Digital Pathology Displays Under Pressure: Benchmarking Performance Across Market Grades.
- Author
-
Marletta S, Caputo A, Guidi G, Pantanowitz L, Pagni F, Bavieri I, L'Imperio V, Brunelli M, Dei Tos AP, and Eccher A
- Abstract
Digital pathology (DP) has transformed the practice of pathology by digitizing pathology glass slides, thereby enhancing diagnostic capabilities. In contrast to radiology, studies comparing the efficiency of DP monitors are limited. This work used a stress test that simulated DP sign-out in practice to evaluate the performance of medical-grade (MG) and consumer off-the-shelf (COTS) displays. Four displays, including three MG and one COTS, were assessed for luminance, contrast ratio, accuracy, and image uniformity. Key metrics, such as luminance uniformity and maximum brightness, were evaluated during a 1-month period that simulated use to reflect an 8-h work day. MG displays outperformed COTS in critical parameters, even though consumer displays were satisfactory for diagnostic purposes. Image uniformity exhibited the most significant variations, with deterioration noted over 2.5% for all displays during the test period. This study compared different types of displays for DP and highlights the importance of regular calibration for maintaining display performance when using DP. Further research is recommended to define validation protocols, including the impact of display aging on DP accuracy., Competing Interests: Declarations. Ethics Approval: This is an observational study. No ethical approval is required. Research Involving Human Participants and/or Animals: Not applicable. Informed Consent: Not applicable. Competing Interests: The authors declare no competing interests., (© 2025. The Author(s).)
- Published
- 2025
- Full Text
- View/download PDF
38. Automate the process of formalin-fixed paraffin-embedded blocks storage in the pathology laboratory: A proof of concept study.
- Author
-
Eccher A, Marletta S, Pagni F, L'Imperio V, Piacentini F, Dominici M, Cavazza A, Pinto C, Brunelli M, Fiorentino M, Malapelle U, Baron MM, Martignoni G, and Dei Tos AP
- Subjects
- Humans, Proof of Concept Study, Automation, Laboratory, Specimen Handling methods, Paraffin Embedding methods, Formaldehyde, Tissue Fixation methods
- Abstract
Pathology laboratories are currently facing remarkable issues in the management of their archives due to the ongoing increase in the production of formalin-fixed paraffin-embedded (FFPE) blocks, which is often coupled with inadequate spatial and environmental storing conditions. The manual process of storage and retrieving further increases the likelihood of human-based mistakes, wastes professionals' working time, and, ultimately, widens reports signing turn-around times. In the present work, we outline the strategies underlying the development of an automated archive at the pathology services of the University of Modena. The proposed project relies on the controlled interaction of a mechanic robotic arm with racks and shelves in a fully traced manner, driven by the integration with the local laboratory information system (LIS). This automated archive aims to significantly improve the time-saving of laboratory professionals and standardize the storage of FFPE samples both before and after the pathology diagnosis is rendered. The system's modularity suits the needs and spaces of the different institutions, opening novel strategies in archiving thanks to its connection with the LIS and integration with artificial intelligence algorithms., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier GmbH. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF
39. Benchmarking digital displays (monitors) for histological diagnoses: the nephropathology use case.
- Author
-
Cazzaniga G, Mascadri F, Marletta S, Caputo A, Guidi G, Gambaro G, Eccher A, Dei Tos AP, Pagni F, and L'Imperio V
- Abstract
Aim: The digital transformation of the pathology laboratory is being continuously sustained by the introduction of innovative technologies promoting whole slide image (WSI)-based primary diagnosis. Here, we proposed a real-life benchmark of a pathology-dedicated medical monitor for the primary diagnosis of renal biopsies, evaluating the concordance between the 'traditional' microscope and commercial monitors using WSI from different scanners., Methods: The College of American Pathologists WSI validation guidelines were used on 60 consecutive renal biopsies from three scanners (Aperio, 3DHISTECH and Hamamatsu) using pathology-dedicated medical grade (MG), professional grade (PG) and consumer-off-the-shelf (COTS) monitors, comparing results with the microscope diagnosis after a 2-week washout period., Results: MG monitor was faster (1090 vs 1159 vs 1181 min, delta of 6-8%, p<0.01), with slightly better performances on the detection of concurrent diseases compared with COTS (κ=1 vs 0.96, 95% CI=0.87 to 1), but equal concordance to the commercial monitors on main diagnosis (κ = 1). Minor discrepancies were noted on specific scores/classifications, with MG and PG monitors closer to the reference report (r=0.98, 95% CI=0.83 to 1 vs 0.98, 95% CI=0.83 to 1 vs 0.91, 95% CI=0.76 to 1, κ=0.93, 95% CI=077 to 1 vs 0.93, 95% CI=0.77 to 1 vs 0.86, 95% CI=0.64 to 1, κ=1 vs 0.50, 95% CI=0 to 1 vs 0.50, 95% CI=0 to 1, for IgA, antineutrophilic cytoplasmic antibody and lupus nephritis, respectively). Streamlined Pipeline for Amyloid detection through congo red fluorescence Digital Analysis detected amyloidosis on both monitors (4 of 30, 13% cases), allowing detection of minimal interstitial deposits with slight overestimation of the Amyloid Score (average 6 vs 7)., Conclusions: The digital transformation needs careful assessment of the hardware component to support a smart and safe diagnostic process. Choosing the display for WSI is critical in the process and requires adequate planning., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
40. Predictive and prognostic biomarkers in cancer: towards the precision medicine era.
- Author
-
Marletta S, Rizzo A, Spoto G, and Falzone L
- Abstract
Competing Interests: Stefano Marletta, Antonio Rizzo, Graziana Spoto, and Luca Falzone who are the Guest Editors of Exploration of Targeted Anti-tumor Therapy, had no involvement in the decision-making or the review process of this manuscript.
- Published
- 2024
- Full Text
- View/download PDF
41. Editorial: Value of a multidisciplinary approach for modern diagnosis of infectious diseases.
- Author
-
Marino A, Stracquadanio S, and Marletta S
- Abstract
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF
42. Case report: STRN3-NTRK3 fusion in uterine sarcoma with spleen metastasis: a new variant in the spectrum of NTRK-rearranged tumors.
- Author
-
Colombo P, Buonamassa GA, Giulianini A, Hassan L, Rudini N, Rizzo A, Cavallo E, Carnaghi C, Goudarzi S, Mongiovì S, Pafumi S, and Marletta S
- Abstract
Neurotrophic tyrosine receptor kinase (NTRK) fusions are infrequent genetic events that can occur in various tumor types. Specifically, NTRK-rearranged sarcoma has been observed in pediatric mesenchymal tumors and, to a lesser extent, in adult mesenchymal tumors like fibrosarcoma. Recently, NTRK-rearranged uterine sarcoma (US) has been identified as a rare entity characterized by constitutive activation or overexpression of the TRK receptor, which plays a role in cell proliferation and differentiation. Since its initial description in 2018, only 46 cases of NTRK-rearranged US have been reported. In this context, herein we describe an exceptional case of an STRN3::NTRK3 fused US with histologically confirmed splenic metastasis. Notably, such localization has not been previously associated with pure uterine sarcomas in the literature. The fusion involved STRN3 (exon-3) and NTRK3 (exon-14) genes and was identified through next-generation sequencing analysis. Recognizing this specific molecular rearrangement is crucial, as it not only enables targeted therapy but also holds diagnostic significance in specific clinical scenarios., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision., (Copyright © 2024 Colombo, Buonamassa, Giulianini, Hassan, Rudini, Rizzo, Cavallo, Carnaghi, Goudarzi, Mongiovì, Pafumi and Marletta.)
- Published
- 2024
- Full Text
- View/download PDF
43. Correction to: Digital pathology structure and deployment in Veneto: a proof-of-concept study.
- Author
-
Eccher A, Marletta S, Sbaraglia M, Guerriero A, Rossi M, Gambaro G, Scarpa A, and Dei Tos AP
- Published
- 2024
- Full Text
- View/download PDF
44. TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum.
- Author
-
Caliò A, Marletta S, Brunelli M, Antonini P, Martelli FM, Marcolini L, Stefanizzi L, and Martignoni G
- Abstract
Background : Identical translocations involving the TFE3 gene and various partners have been found in both renal and soft tissue tumors, like alveolar soft part sarcoma ( ASPSCR1 ), ossifying fibromyxoid tumor ( PHF1 ), epithelioid hemangioendothelioma, and the clear cell stromal tumor of the lung ( YAP1 ). Methods : Herein, we review in detail the clinicopathologic and molecular data of TFE3-rearranged renal tumors and propose our perspective, which may shed light on this emerging conundrum. Results : Among the kidney tumors carrying TFE3 translocations, most are morphologically heterogeneous carcinomas labeling for the tubular marker PAX8. The others are mesenchymal neoplasms known as PEComas, characterized by epithelioid cells co-expressing smooth muscle actin, cathepsin-K, melanogenesis markers, and sometimes melanin pigment deposition. Over the past 30 years, numerous TFE3 fusion partners have been identified, with ASPL/ASPSCR1 , PRCC , SFPQ/PSF , and NONO being the most frequent. Conclusions : It is not well understood why similar gene fusions can give rise to renal tumors with different morpho-immunophenotypes, which may contribute to the recent disagreement regarding their classification. However, as these two entities, respectively, epithelial and mesenchymal in nature, are widely recognized by the pathology community and their clinicopathologic features well established, we overall believe it is still better to retain the names TFE3-rearranged renal cell carcinoma and TFE3-rearranged PEComa.
- Published
- 2024
- Full Text
- View/download PDF
45. Galileo-an Artificial Intelligence tool for evaluating pre-implantation kidney biopsies.
- Author
-
Eccher A, L'Imperio V, Pantanowitz L, Cazzaniga G, Del Carro F, Marletta S, Gambaro G, Barreca A, Becker JU, Gobbo S, Della Mea V, Alberici F, Pagni F, and Dei Tos AP
- Abstract
Background: Pre-transplant procurement biopsy interpretation is challenging, also because of the low number of renal pathology experts. Artificial intelligence (AI) can assist by aiding pathologists with kidney donor biopsy assessment. Herein we present the "Galileo" AI tool, designed specifically to assist the on-call pathologist with interpreting pre-implantation kidney biopsies., Methods: A multicenter cohort of whole slide images acquired from core-needle and wedge biopsies of the kidney was collected. A deep learning algorithm was trained to detect the main findings evaluated in the pre-implantation setting (normal glomeruli, globally sclerosed glomeruli, ischemic glomeruli, arterioles and arteries). The model obtained on the Aiforia Create platform was validated on an external dataset by three independent pathologists to evaluate the performance of the algorithm., Results: Galileo demonstrated a precision, sensitivity, F1 score and total area error of 81.96%, 94.39%, 87.74%, 2.81% and 74.05%, 71.03%, 72.5%, 2% in the training and validation sets, respectively. Galileo was significantly faster than pathologists, requiring 2 min overall in the validation phase (vs 25, 22 and 31 min by 3 separate human readers, p < 0.001). Galileo-assisted detection of renal structures and quantitative information was directly integrated in the final report., Conclusions: The Galileo AI-assisted tool shows promise in speeding up pre-implantation kidney biopsy interpretation, as well as in reducing inter-observer variability. This tool may represent a starting point for further improvements based on hard endpoints such as graft survival., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
46. Digital pathology structure and deployment in Veneto: a proof-of-concept study.
- Author
-
Eccher A, Marletta S, Sbaraglia M, Guerriero A, Rossi M, Gambaro G, Scarpa A, and Dei Tos AP
- Subjects
- Humans, Italy, Pathology, Clinical methods, Workflow, Image Interpretation, Computer-Assisted methods, Artificial Intelligence, Telepathology, Proof of Concept Study
- Abstract
Nowadays pathology laboratories are worldwide facing a digital revolution, with an increasing number of institutions adopting digital pathology (DP) and whole slide imaging solutions. Despite indeed providing novel and helpful advantages, embracing a whole DP workflow is still challenging, especially for wide healthcare networks. The Azienda Zero of the Veneto Italian region has begun a process of a fully digital transformation of an integrated network of 12 hospitals producing nearly 3 million slides per year. In the present article, we describe the planning stages and the operative phases needed to support such a disruptive transition, along with the initial preliminary results emerging from the project. The ultimate goal of the DP program in the Veneto Italian region is to improve patients' clinical care through a safe and standardized process, encompassing a total digital management of pathology samples, easy file sharing with experienced colleagues, and automatic support by artificial intelligence tools., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
47. Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma.
- Author
-
Caliò A, Marletta S, Stefanizzi L, Marcolini L, Rotellini M, Serio G, Bariani E, Vicentini C, Pedron S, Martelli FM, Antonini P, Brunelli M, and Martignoni G
- Subjects
- Humans, Female, Middle Aged, Male, Aged, Adult, Diagnosis, Differential, B7-H1 Antigen analysis, Mesothelioma, Malignant pathology, Mesothelioma, Malignant genetics, Mesothelioma, Malignant enzymology, Mutation, Immunohistochemistry, Kidney Neoplasms pathology, Kidney Neoplasms genetics, Carcinoma, Renal Cell genetics, Carcinoma, Renal Cell pathology, Peritoneal Neoplasms genetics, Peritoneal Neoplasms secondary, Fumarate Hydratase deficiency, Fumarate Hydratase genetics, Biomarkers, Tumor genetics, Biomarkers, Tumor analysis
- Abstract
Fumarate hydratase (FH)-deficient renal cell carcinomas are rare neoplasms characterized by wide morphologic heterogeneity and pathogenetic mutations in the FH gene. They often show aggressive behavior with rapid diffusion to distant organs, so novel therapeutic scenarios have been explored, including EGFR inhibitors and PD-L1 expression for targeted immunotherapy. Herein, we investigated a series of 11 primary FH-deficient renal cell carcinomas and 7 distant metastases to evaluate tumor heterogeneity even in metastatic sites and estimate the specific spread rates to various organs. Furthermore, the tumors were tested for immunohistochemical PD-L1 expression and EGFR mutations. Most metastatic cases involved the abdominal lymph nodes (4/7; 57%), followed by the peritoneum (3/7; 42%), the liver (2/7; 29%), and the lungs (1/7; 14%). Six metastatic localizations were histologically documented, revealing a morphologic heterogeneous architecture often differing from that of the corresponding primary renal tumor. Peritoneal involvement morphologically resembled a benign reactive mesothelial process or primary peritoneal mesothelioma, thus advocating to perform an accurate immunohistochemical panel, including PAX8 and FH, to reach a proper diagnosis. A pure low-grade succinate dehydrogenase-looking primary FH-deficient renal cell carcinoma was also recorded. As for therapy, significant PD-L1 labeling was found in 60% of primary renal tumors, whereas none of them carried pathogenetic EGFR mutations. Our data show that FH-deficient renal cell carcinoma may be morphologically heterogeneous in metastases as well, which involve the lymph nodes, the liver, and the peritoneum more frequently than other renal tumors. Due to the high frequency of this latter (42%), pathologists should always be concerned about ruling out mesothelial-derived mimickers, and the occurrence of rarer, primary, low-grade-looking types. Finally, contrary to EGFR mutations, PD-L1 expression could be a possible predictive biomarker for the therapy of these tumors., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
48. Real-world biomarker testing patterns: clinical-pathological portrait of early and late non-small cell lung cancer in hub and spoke North Italian centers.
- Author
-
Tinè M, Pezzuto F, Orlandi M, Caliò A, Marletta S, Bondavalli T, Giongo D, Reghellin D, Posenato I, Santacatterina M, Menin A, Welte PK, Baciorri F, Sacchi D, Catino C, Nicolè L, Foltran G, D'Urso A, Orzes N, Andreotti G, Bartolotta P, Gregori D, Pasello G, Rea F, and Calabrese F
- Abstract
Background: Lung cancer is still the main cause of cancer death. In the last decades, significant innovations were introduced in non-small cell lung cancer (NSCLC) treatment and management improving patient outcomes. The discovery of immune checkpoint inhibitors and the detection of an increasing list of actionable genetic alterations are enabling a tailored approach. Herein, we assessed in a pragmatic retrospective study the rate of biomarker tests within a large pulmonary pathology-based unit (PPU) network of the Veneto region (Northern Italy)., Methods: Each PPU of 7 hubs and spoke centers implemented a biomarker database with pathologic and clinical data of patients with NSCLC diagnosis over 24 months., Results: Out of 1,817 NSCLC cases, 51% were advanced and 49% early stage, with 72% being adenocarcinomas. Programmed death ligand 1 expression and epidermal growth factor receptor mutations were available in most samples, 91% and 78%, respectively. Only 36% of advanced stages received all 5 biomarker tests with an increased rate over time. Co-occurring molecular alterations were detected in 42 cases (2%): the prevalence was (n=17) 41% and (n=25) 59% in early and late-stage adenocarcinomas, respectively., Conclusions: In this real-world study, while most patients received at least one biomarker test, less than 50% had all 5 biomarkers. The screening appeared to increase over time especially with the progressive use of next generation sequencing. Our results confirm the importance of systematic biomarker testing including all NSCLCs based on the evidence of several genomic alterations also in early-stage disease whose analysis may become relevant as neo-adjuvant targeted therapies are available., Keywords: Non-small cell lung cancer (NSCLC); biomarkers; actionable targets; lung cancer., Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-24-107/coif). The authors have no conflicts of interest to declare., (2024 Translational Lung Cancer Research. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
49. Response to Letter to the Editor: "Remote Placental Sign-Out: What Digital Pathology Can Offer for Pediatric Pathologists".
- Author
-
Marletta S, Pantanowitz L, Santonicco N, Caputo A, Bragantini E, Brunelli M, Girolami I, and Eccher A
- Subjects
- Humans, Female, Pregnancy, Pathologists, Telepathology, Pathology, Clinical methods, Placenta pathology
- Abstract
Competing Interests: Declaration of Conflicting InterestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
50. Artificial intelligence-based algorithms for the diagnosis of prostate cancer: A systematic review.
- Author
-
Marletta S, Eccher A, Martelli FM, Santonicco N, Girolami I, Scarpa A, Pagni F, L'Imperio V, Pantanowitz L, Gobbo S, Seminati D, Dei Tos AP, and Parwani A
- Subjects
- Humans, Male, Prostatic Neoplasms diagnosis, Prostatic Neoplasms pathology, Artificial Intelligence, Algorithms
- Abstract
Objectives: The high incidence of prostate cancer causes prostatic samples to significantly affect pathology laboratories workflow and turnaround times (TATs). Whole-slide imaging (WSI) and artificial intelligence (AI) have both gained approval for primary diagnosis in prostate pathology, providing physicians with novel tools for their daily routine., Methods: A systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines was carried out in electronic databases to gather the available evidence on the application of AI-based algorithms to prostate cancer., Results: Of 6290 articles, 80 were included, mostly (59%) dealing with biopsy specimens. Glass slides were digitized to WSI in most studies (89%), roughly two-thirds of which (66%) exploited convolutional neural networks for computational analysis. The algorithms achieved good to excellent results about cancer detection and grading, along with significantly reduced TATs. Furthermore, several studies showed a relevant correlation between AI-identified histologic features and prognostic predictive variables such as biochemical recurrence, extraprostatic extension, perineural invasion, and disease-free survival., Conclusions: The published evidence suggests that AI can be reliably used for prostate cancer detection and grading, assisting pathologists in the time-consuming screening of slides. Further technologic improvement would help widening AI's adoption in prostate pathology, as well as expanding its prognostic predictive potential., (© The Author(s) 2024. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.